AI assistant
Sending…
Cardlytics, Inc. — Director's Dealing 2019
Oct 30, 2019
33956_dirs_2019-10-30_89342a83-b7e3-4530-abb4-2316f0bd2df3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2019-10-29
Reporting Person: Evans David Thomas (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-29 | Common Stock | M | 3906 | $20 | Acquired | 53471 | Direct |
| 2019-10-29 | Common Stock | S | 6906 | $40 | Disposed | 46565 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-10-29 | Employee Stock Option (Right to Buy) | $20.0 | M | 3906 | Disposed | 2026-08-02 | Common Stock (3906.0) | Direct |
Footnotes
F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019.
F2: Fully vested.
More from Cardlytics, Inc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 26